We report a case of acute myeloid leukemia (AML) M1 showing a 48,XY,+13,+13 karyotype. Treatment was according to the Medical Research Council AML14 trial protocol with two courses of DAT chemotherapy. Postchemotherapy bone marrow examination failed to show complete remission or cytogenetic normalization. Despite having resistant disease, the patient initially remained clinically well although requiring regular blood transfusions for anemia. However his leukocyte count gradually increased and he became symptomatic. He was treated subsequently with FLAG but died approximately 2 weeks later, 6 months after first presenting. Tetrasomy 13 as the sole cytogenetic abnormality has not been reported previously in M1 AML and has only been reported in three other AML cases, all with an immature phenotype and poor outcome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0165-4608(01)00651-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18.
Sci Rep
October 2021
Cancer and Leukaemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), 08916, Badalona, Spain.
Haematopoietic malignancies are frequently characterized by karyotypic abnormalities. The development of targeted drugs has been pioneered with compounds against gene products of fusion genes caused by chromosomal translocations. While polysomies are equally frequent as translocations, for many of them we are lacking therapeutic approaches aimed at synthetic lethality.
View Article and Find Full Text PDFUnclassifiable pattern of hypopigmentation in a patient with mosaic partial 12p tetrasomy without Pallister-Killian syndrome.
Am J Med Genet A
July 2017
Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Article Synopsis
- - Pallister-Killian syndrome (PKS) is a genetic disorder caused by an extra chromosomal marker on chromosome 12, leading to various developmental issues and physical abnormalities.
- - A case study is presented of a 4-year-old girl with a significant presence of aneuploid cells, yet she exhibits only mild symptoms, showing a type of pigmentary mosaicism rather than the classic PKS phenotype.
- - This case suggests that even partial 12p chromosomal abnormalities can lead to milder manifestations than previously thought, indicating the need for better dermatologic evaluations to aid in genetic testing.
Trisomy 8 in leukemia: A GCRI experience.
Indian J Hum Genet
January 2012
Department of Cancer Biology, Cell Biology Division, The Gujarat Cancer and Research Institute, NCH Campus, Asarwa, Ahmedabad, Gujarat, India.
Trisomy of chromosome 8 is frequently reported in myeloid lineage disorders and also detected in lymphoid neoplasms as well as solid tumors suggesting its role in neoplastic progression in general. It is likely to be a disease-modulating secondary event with underlying cryptic aberrations as it has been frequently reported in addition to known abnormalities contributing to clinical heterogeneity and modifying prognosis. Here, we share our findings of trisomy 8 in leukemia patients referred for diagnostic and prognostic cytogenetic assessment.
View Article and Find Full Text PDFAbsence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas.
Cancer Genet
July 2011
Laboratori de Citogenètica Molecular, Laboratori de Citologia Hematològica, Servei de Patologia, Hospital del Mar-Parc de Salut Mar, IMIM-Institut de Recerca de l'Hospital del Mar, Programa de Recerca en Càncer, GRETNHE, Barcelona, Spain.
Chromosomal aberrations involving T-cell receptor (TCR) gene loci have been described in several T-cell malignancies. In primary cutaneous T-cell lymphomas (CTCL), the frequency of these aberrations has not yet been well established. We analyzed TCR gene loci (TCRAD, TCRB, and TCRG) status in CTCLs by fluorescence in situ hybridization (FISH).
View Article and Find Full Text PDFTetrasomy 8 in a patient with chronic lymphocytic leukemia.
Cancer Genet Cytogenet
April 2010
Department of Internal Medicine, Division of Hematology, School of Medicine of Ribeirão Preto, University of São Paulo, 14049-900 Ribeirão Preto, SP, Brazil.
We report a case of a 47-year-old man diagnosed with chronic lymphocytic leukemia (CLL) with two extra copies of chromosome 8. Classical cytogenetic analysis by the immunostimulatory combination of DSP30 and interleukin 2 showed tetrasomy of chromosome 8 in 60% of the metaphase cells (48,XY,+8,+8[12]/46,XY[8]). Spectral karyotype analysis confirmed the abnormality previously seen by G banding.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!